Immune checkpoint inhibitors in cancer therapy: Review of orofacial adverse events and role of the oral healthcare provider

Immune checkpoint inhibitors (ICIs) are a revolutionary class of antineoplastic therapy that restore anti-tumor immunity. Consequences of this enhanced immune response include a multitude of immune related adverse events (irAEs) that can affect any body system, including the mouth. Orofacial irAEs r...

Descripción completa

Detalles Bibliográficos
Autores principales: Klein, Brittany A., Shazib, Muhammad Ali, Villa, Alessandro, de Abreu Alves, Fábio, Vacharotayangul, Piamkamon, Sonis, Stephen, Fedele, Stefano, Treister, Nathaniel S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oral Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427772/
https://www.ncbi.nlm.nih.gov/pubmed/36060116
http://dx.doi.org/10.3389/froh.2022.968157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427772/
https://www.ncbi.nlm.nih.gov/pubmed/36060116
http://dx.doi.org/10.3389/froh.2022.968157

Ejemplares similares